Launch of EAHAD Unified Coagulation Factor Variant Databases
We are pleased to report that the existing EAHAD individual coagulation factor variant web databases have been brought together into a single unified site at https://dbs.eahad.org. This move harmonizes all existing EAHAD databases and takes advantage of improvements in web hosting and security. The unified site collects…
Looking for an informative and engaging podcast on bleeding disorders? Look no further than the EAHAD Podcast, now available on Spotify Podcasts! Hosted by experts in the field, the EAHAD Podcast is your go-to source for the latest news, research, and information on bleeding disorders. Our very first episode features the E-learning Working Group and focuses…
With the new changing landscape of haemophilia treatment in Europe, EAHAD, in partnership with the European Haemophilia Consortium, decided not only to continue with the certification project first started in 2013 but also to review and update it in order to reflect the specialised services required to monitor patients who may receive new treatments.
This e-learning module provides an up-to-date overview of Hereditary Hemorrhagic Telangiectasia (HHT), a rare autosomal dominant vascular disorder characterized by abnormal blood vessel formation and recurrent bleeding. You will review the genetic basis, pathophysiology, clinical manifestations, diagnostic criteria, and current management strategies for HHT.
Watch it now
Page (post) title HomePage (post) title
The EAHAD Research Grant Review Panel will review all complete applications submitted for a research grant. The top-ranking applications after the first-round review will be sent to external reviewers. External reviewers will be asked to score the applications according to a five-point scale basing their evaluation on study design, level…
Page (post) title HomePage (post) title
The EAHAD Accreditation Panel for European Haemophilia Centres is established under the EAHAD Accreditation and Audit of Haemophilia Centres Working Group. The purpose of the Panel is to support the accreditation of European Haemophilia Centres by reviewing applications submitted to EAHAD and assessing whether applicant centres meet the requirements set…
Page (post) title HomePage (post) title
The goal of the EAHAD Guidelines and Guidance Panel is to provide a clear, efficient, and credible mechanism for the review and oversight of EAHAD guidance-related activities. The Panel’s work focuses on: assessing requests for new guidance, guidelines, consensus papers, and principles documents; determining the most suitable format for…
Are you a clinician actively involved in the haemophilia and bleeding disorders field and a dedicated member of EAHAD? If so, we're happy to inform you that we've just launched the EAHAD 2030 Request for Proposals (RFP)! EAHAD is a multidisciplinary association comprising healthcare professionals from various backgrounds, including haematologists, internists, paediatricians, nurses, physiotherapists, laboratory…
Gene therapy is changing the treatment landscape of haemophilia, but inhibitor development remains a key clinical and scientific question. This webinar will provide an integrated overview of the immunological mechanisms involved in inhibitor development, insights from real clinical cases following gene therapy, and a critical review of current clinical studies addressing the relevance of inhibitors…
Page (post) title HomePage (post) title
EAHAD 2026
The nurses’ stream at EAHAD 2026 in Dublin was attended by a highly engaged audience and inspirational speakers. Throughout the day, we explored key concepts of care for people affected by bleeding disorders. Here is a summary of the main highlights and takeaways from the day. Joint Session…
